Hony Capital trims stake in CSPC Pharmaceutical by $154 million

The upsized deal comes at a 10.2% discount and will open the door for the private equity firm to convert part of an $860 million CB following a surge in the share price.
April 26, 2013

A company controlled by Chinese private equity firm Hony Capital last night sold part of its stake in Hong Kong-listed CSPC Pharmaceutical, raising HK$1.2 billion ($154 million).

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media